The University of Chicago Header Logo

Connection

Russell Z. Szmulewitz to Mifepristone

Back to Details
This is a "connection" page, showing publications Russell Z. Szmulewitz has written about Mifepristone.
Russell Z. Szmulewitz
Connection Strength
0.321
Mifepristone
  1. Phase I/II Trial of Enzalutamide and Mifepristone, a Glucocorticoid Receptor Antagonist, for Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2022 04 14; 28(8):1549-1559.
    View in: PubMed
    Score: 0.204
  2. Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer. Horm Cancer. 2014 Apr; 5(2):72-89.
    View in: PubMed
    Score: 0.117
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.